Inogen, Inc (INGN): Price and Financial Metrics

Inogen, Inc (INGN): $46.73

-0.02 (-0.04%)

POWR Rating

Component Grades














  • Value is the dimension where INGN ranks best; there it ranks ahead of 84.98% of US stocks.
  • INGN's strongest trending metric is Sentiment; it's been moving up over the last 48 weeks.
  • INGN's current lowest rank is in the Growth metric (where it is better than 44.51% of US stocks).

INGN Stock Summary

  • INGN's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 711.51 -- higher than 95.59% of US-listed equities with positive expected earnings growth.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.33 for Inogen Inc; that's greater than it is for just 17.42% of US stocks.
  • With a year-over-year growth in debt of 170.76%, Inogen Inc's debt growth rate surpasses 94.72% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Inogen Inc are TREE, CSPI, EVER, OFIX, and ANGI.
  • INGN's SEC filings can be seen here. And to visit Inogen Inc's official web site, go to

INGN Valuation Summary

  • INGN's price/sales ratio is 4; this is 5.26% higher than that of the median Healthcare stock.
  • Over the past 92 months, INGN's price/sales ratio has gone up 0.4.
  • Over the past 92 months, INGN's price/earnings ratio has gone down 557.

Below are key valuation metrics over time for INGN.

Stock Date P/S P/B P/E EV/EBIT
INGN 2021-08-31 4.0 3.6 -546.2 451.0
INGN 2021-08-30 4.0 3.6 -544.5 449.3
INGN 2021-08-27 4.0 3.6 -550.2 454.9
INGN 2021-08-26 3.9 3.5 -535.1 440.1
INGN 2021-08-25 4.0 3.6 -551.1 455.7
INGN 2021-08-24 4.1 3.7 -563.3 467.7

INGN Growth Metrics

  • Its 5 year cash and equivalents growth rate is now at 278.22%.
  • The 2 year net cashflow from operations growth rate now stands at -27.83%.
  • Its year over year cash and equivalents growth rate is now at 5.59%.
INGN's revenue has moved up $189,125,000 over the prior 70 months.

The table below shows INGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 336.802 43.072 -2.45
2021-03-31 306.93 39.333 -4.972
2020-12-31 308.487 37.013 -5.829
2020-09-30 313.426 30.204 -2.083
2020-06-30 330.858 38.06 6.479
2020-03-31 360.23 42.957 14.059

INGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INGN has a Quality Grade of C, ranking ahead of 46.7% of graded US stocks.
  • INGN's asset turnover comes in at 0.71 -- ranking 49th of 183 Medical Equipment stocks.
  • ATRC, ABMD, and BSX are the stocks whose asset turnover ratios are most correlated with INGN.

The table below shows INGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.710 0.467 0.022
2021-03-31 0.661 0.455 -0.057
2020-12-31 0.671 0.448 -0.053
2020-09-30 0.687 0.440 -0.044
2020-06-30 0.731 0.448 0.060
2020-03-31 0.821 0.460 0.140

INGN Price Target

For more insight on analysts targets of INGN, see our INGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $71.00 Average Broker Recommendation 1.92 (Hold)

INGN Stock Price Chart Interactive Chart >

Price chart for INGN

INGN Price/Volume Stats

Current price $46.73 52-week high $82.35
Prev. close $46.75 52-week low $26.90
Day low $46.61 Volume 107,600
Day high $47.74 Avg. volume 170,169
50-day MA $62.03 Dividend yield N/A
200-day MA $57.25 Market Cap 1.06B

Inogen, Inc (INGN) Company Bio

Inogen develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company was founded in 2001 and is based in Goleta, California.

INGN Latest News Stream

Event/Time News Detail
Loading, please wait...

INGN Latest Social Stream

Loading social stream, please wait...

View Full INGN Social Stream

Latest INGN News From Around the Web

Below are the latest news stories about Inogen Inc that investors may wish to consider to help them evaluate INGN as an investment opportunity.

Here's Why You Should Retain Inogen (INGN) Stock For Now

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Yahoo | September 21, 2021

Inogen Strengthens Commercial Capabilities Through New Ashfield Relationship

GOLETA, Calif., September 21, 2021--Inogen, Inc. (NASDAQ: INGN), ("Inogen" or "the Company"), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced an agreement to enhance its go-to-market capabilities with Ashfield Healthcare, LLC, part of UDG Healthcare ("Ashfield").

Yahoo | September 21, 2021

Inogen (INGN) Shareholder Litigation Alert: Should Inogen Management be Held Accountable for Investors Losses? Contact Johnson Fistel, LLP Regarding Pending Derivative Case

SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, the court-appointed Lead Counsel in a derivative action brought for the benefit of Inogen, Inc. (NASDAQ: INGN) and its shareholders, announces today that a securities fraud class action pending before U.S. District Judge Fernando M. Olguin in the Central District of California against Inogen, captioned In re Inogen, Inc. Sec. Litig., No. CV 19-1643, remains alive despite Judge Olguin’s August 13, 2021 order granting the defendant

Yahoo | September 2, 2021

Inogen stock suffers record plunge as chip shortage to hurt sales, margins for another year

Chief Executive Nabil Shabshab said demand for POCs and pricing has been strong, given higher rates of vaccination for COVID-19 and an “increased desire for mobility” as pandemic-related restrictions have been lifted. Read more about the chip shortage.

Yahoo | August 6, 2021

Inogen (INGN) Stock Loses 26.7% In Spite of Q2 Earnings Beat

Inogen's (INGN) second-quarter results benefit from higher revenues across its segments.

Yahoo | August 6, 2021

Read More 'INGN' Stories Here

INGN Price Returns

1-mo -21.74%
3-mo -29.73%
6-mo -3.21%
1-year 69.87%
3-year -81.93%
5-year -23.44%
YTD 4.59%
2020 -34.61%
2019 -44.97%
2018 4.27%
2017 77.28%
2016 67.55%

Continue Researching INGN

Want to see what other sources are saying about Inogen Inc's financials and stock price? Try the links below:

Inogen Inc (INGN) Stock Price | Nasdaq
Inogen Inc (INGN) Stock Quote, History and News - Yahoo Finance
Inogen Inc (INGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8404 seconds.